Body Mass Index Is Associated with Post-Acute Elevations in Biomarkers of Platelet Activation and Inflammation in Unvaccinated Adults Diagnosed with COVID-19 in the Previous 8 Weeks
Obesity Facts · 2024
DOI: 10.1159/000540343 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obesity Facts, 2024. Verfasst von Samantha N Fessler und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Solutions, Arizona State University, Tempe, Arizona, USA. Hauptthemen laut MEDLINE: Biomarkers, Body Mass Index, COVID-19, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Obesity has arisen as a prominent risk factor for COVID-19 severity and long COVID, potentially owed in part to the obesity-induced proinflammatory state. This study aimed to examine relationships among circulating inflammatory biomarkers and body mass index in nonhospitalized adults recently diagnosed with COVID-19.
Methods
This analysis included participants who completed a randomized placebo-controlled trial conducted in October 2020–March 2021.
Participants
(19–53 years) were unvaccinated and enrolled following COVID-19 diagnosis as allowed by CDC return-to-work guidance. Anthropometrics and biomarkers were assessed at study baseline and week four. We examined the associations between body mass index (BMI) and inflammatory biomarkers via multiple regression models.
Results
At study baseline (i.e., the point of enrollment following COVID-19 diagnosis) across all participants (N = 60), a higher BMI was associated with elevations in several inflammatory biomarkers including IL-6 (β = 7.63, 95% CI = 3.54, 11.89, p = 0.0004), ferritin (β = 6.31, 95% CI = 1.97, 10.83, p = 0.0047), high sensitivity C-reactive protein (β = 13.1, 95% CI = 8.03, 18.42, p = < 0.0001), tumor necrosis factor-α (β = 3.23, 95% CI = 0.91, 5.60, p = 0.0069), IL-12p40 (β = 3.69, 95% CI = 0.93, 6.52, p = 0.0094), IL-13 (β = 5.11, 95% CI = 1.00, 9.40, p = 0.0154), and IL-1Ra (β = 7.57, 95% CI = 3.61, 11.70, p = 0.0003). In control group participants (n = 30) after 4 weeks, a higher BMI was associated with elevations in IL-4 (β = 17.8, 95% CI = 0.84, 37.6, p = 0.0397) and sP-selectin (β = 1.16, 95% CI = 0.22, 2.11, p = 0.0182), controlling for baseline and covariates.
Conclusions
Here, BMI was positively associated with circulating biomarkers of platelet activation and inflammation in adults recently diagnosed with COVID-19 after 4 weeks. The shift in post-acute COVID-19 inflammatory biomarkers associated with an increasing BMI noted here shares similarities to biomarkers of LC reported in the literature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health Solutions, Arizona State University, Tempe, Arizona, USA.
- Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
- School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Zitieren
APA
Fessler, S. N., Liu, L., Chang, Y., & Johnston, C. S. (2024). Body Mass Index Is Associated with Post-Acute Elevations in Biomarkers of Platelet Activation and Inflammation in Unvaccinated Adults Diagnosed with COVID-19 in the Previous 8 Weeks. Obesity Facts. https://doi.org/10.1159/000540343
Vancouver
Fessler SN, Liu L, Chang Y, Johnston CS. Body Mass Index Is Associated with Post-Acute Elevations in Biomarkers of Platelet Activation and Inflammation in Unvaccinated Adults Diagnosed with COVID-19 in the Previous 8 Weeks. Obesity Facts. 2024. doi:10.1159/000540343
BibTeX
@article{Fessler2024,
author = {Fessler, Samantha N and Liu, Li and Chang, Yung and Johnston, Carol S},
title = {Body Mass Index Is Associated with Post-Acute Elevations in Biomarkers of Platelet Activation and Inflammation in Unvaccinated Adults Diagnosed with COVID-19 in the Previous 8 Weeks},
journal = {Obesity Facts},
year = {2024},
doi = {10.1159/000540343}
}
EUVIMED